Global Multiplex Molecular Diagnostic Market Research Report 2023

December 2023 | 88 pages | ID: G63A0B8AF890EN
QYResearch

Abstracts

Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.

According to QYResearch’s new survey, global Multiplex Molecular Diagnostic market is projected to reach US$ 8522.7 million in 2029, increasing from US$ 5362 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multiplex Molecular Diagnostic market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiplex Molecular Diagnostic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• BD
• bioMйrieux
• SpeeDx
• Roche
• Contextual Genomics
• GenMark Diagnostics
• Hologic
• Luminex Corporation
• Binx Health

Segment by Type

• Real-time PCR
• Nested PCR with Melt Curve Analysis
• PCR with Low density Microarray
• PCR with Liquid Phase Bead Array
• PCR with Electrochemical Detection

Segment by Application

• Clinical Research Laboratory
• Hospitals
• Academic and Research Centers
• Others

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Multiplex Molecular Diagnostic report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Real-time PCR
  1.2.3 Nested PCR with Melt Curve Analysis
  1.2.4 PCR with Low density Microarray
  1.2.5 PCR with Liquid Phase Bead Array
  1.2.6 PCR with Electrochemical Detection
1.3 Market by Application
  1.3.1 Global Multiplex Molecular Diagnostic Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Clinical Research Laboratory
  1.3.3 Hospitals
  1.3.4 Academic and Research Centers
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Multiplex Molecular Diagnostic Market Perspective (2018-2029)
2.2 Multiplex Molecular Diagnostic Growth Trends by Region
  2.2.1 Global Multiplex Molecular Diagnostic Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Multiplex Molecular Diagnostic Historic Market Size by Region (2018-2023)
  2.2.3 Multiplex Molecular Diagnostic Forecasted Market Size by Region (2024-2029)
2.3 Multiplex Molecular Diagnostic Market Dynamics
  2.3.1 Multiplex Molecular Diagnostic Industry Trends
  2.3.2 Multiplex Molecular Diagnostic Market Drivers
  2.3.3 Multiplex Molecular Diagnostic Market Challenges
  2.3.4 Multiplex Molecular Diagnostic Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Multiplex Molecular Diagnostic Players by Revenue
  3.1.1 Global Top Multiplex Molecular Diagnostic Players by Revenue (2018-2023)
  3.1.2 Global Multiplex Molecular Diagnostic Revenue Market Share by Players (2018-2023)
3.2 Global Multiplex Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplex Molecular Diagnostic Revenue
3.4 Global Multiplex Molecular Diagnostic Market Concentration Ratio
  3.4.1 Global Multiplex Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Multiplex Molecular Diagnostic Revenue in 2022
3.5 Multiplex Molecular Diagnostic Key Players Head office and Area Served
3.6 Key Players Multiplex Molecular Diagnostic Product Solution and Service
3.7 Date of Enter into Multiplex Molecular Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 MULTIPLEX MOLECULAR DIAGNOSTIC BREAKDOWN DATA BY TYPE

4.1 Global Multiplex Molecular Diagnostic Historic Market Size by Type (2018-2023)
4.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2024-2029)

5 MULTIPLEX MOLECULAR DIAGNOSTIC BREAKDOWN DATA BY APPLICATION

5.1 Global Multiplex Molecular Diagnostic Historic Market Size by Application (2018-2023)
5.2 Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Multiplex Molecular Diagnostic Market Size (2018-2029)
6.2 North America Multiplex Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
6.4 North America Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Multiplex Molecular Diagnostic Market Size (2018-2029)
7.2 Europe Multiplex Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
7.4 Europe Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Multiplex Molecular Diagnostic Market Size (2018-2029)
8.2 Asia-Pacific Multiplex Molecular Diagnostic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2018-2023)
8.4 Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Multiplex Molecular Diagnostic Market Size (2018-2029)
9.2 Latin America Multiplex Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
9.4 Latin America Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Multiplex Molecular Diagnostic Market Size (2018-2029)
10.2 Middle East & Africa Multiplex Molecular Diagnostic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2018-2023)
10.4 Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 BD
  11.1.1 BD Company Detail
  11.1.2 BD Business Overview
  11.1.3 BD Multiplex Molecular Diagnostic Introduction
  11.1.4 BD Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.1.5 BD Recent Development
11.2 bioMйrieux
  11.2.1 bioMйrieux Company Detail
  11.2.2 bioMйrieux Business Overview
  11.2.3 bioMйrieux Multiplex Molecular Diagnostic Introduction
  11.2.4 bioMйrieux Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.2.5 bioMйrieux Recent Development
11.3 SpeeDx
  11.3.1 SpeeDx Company Detail
  11.3.2 SpeeDx Business Overview
  11.3.3 SpeeDx Multiplex Molecular Diagnostic Introduction
  11.3.4 SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.3.5 SpeeDx Recent Development
11.4 Roche
  11.4.1 Roche Company Detail
  11.4.2 Roche Business Overview
  11.4.3 Roche Multiplex Molecular Diagnostic Introduction
  11.4.4 Roche Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.4.5 Roche Recent Development
11.5 Contextual Genomics
  11.5.1 Contextual Genomics Company Detail
  11.5.2 Contextual Genomics Business Overview
  11.5.3 Contextual Genomics Multiplex Molecular Diagnostic Introduction
  11.5.4 Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.5.5 Contextual Genomics Recent Development
11.6 GenMark Diagnostics
  11.6.1 GenMark Diagnostics Company Detail
  11.6.2 GenMark Diagnostics Business Overview
  11.6.3 GenMark Diagnostics Multiplex Molecular Diagnostic Introduction
  11.6.4 GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.6.5 GenMark Diagnostics Recent Development
11.7 Hologic
  11.7.1 Hologic Company Detail
  11.7.2 Hologic Business Overview
  11.7.3 Hologic Multiplex Molecular Diagnostic Introduction
  11.7.4 Hologic Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.7.5 Hologic Recent Development
11.8 Luminex Corporation
  11.8.1 Luminex Corporation Company Detail
  11.8.2 Luminex Corporation Business Overview
  11.8.3 Luminex Corporation Multiplex Molecular Diagnostic Introduction
  11.8.4 Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.8.5 Luminex Corporation Recent Development
11.9 Binx Health
  11.9.1 Binx Health Company Detail
  11.9.2 Binx Health Business Overview
  11.9.3 Binx Health Multiplex Molecular Diagnostic Introduction
  11.9.4 Binx Health Revenue in Multiplex Molecular Diagnostic Business (2018-2023)
  11.9.5 Binx Health Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Multiplex Molecular Diagnostic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Real-time PCR
Table 3. Key Players of Nested PCR with Melt Curve Analysis
Table 4. Key Players of PCR with Low density Microarray
Table 5. Key Players of PCR with Liquid Phase Bead Array
Table 6. Key Players of PCR with Electrochemical Detection
Table 7. Global Multiplex Molecular Diagnostic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Multiplex Molecular Diagnostic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Multiplex Molecular Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Multiplex Molecular Diagnostic Market Share by Region (2018-2023)
Table 11. Global Multiplex Molecular Diagnostic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Multiplex Molecular Diagnostic Market Share by Region (2024-2029)
Table 13. Multiplex Molecular Diagnostic Market Trends
Table 14. Multiplex Molecular Diagnostic Market Drivers
Table 15. Multiplex Molecular Diagnostic Market Challenges
Table 16. Multiplex Molecular Diagnostic Market Restraints
Table 17. Global Multiplex Molecular Diagnostic Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Multiplex Molecular Diagnostic Market Share by Players (2018-2023)
Table 19. Global Top Multiplex Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2022)
Table 20. Ranking of Global Top Multiplex Molecular Diagnostic Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Multiplex Molecular Diagnostic Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Multiplex Molecular Diagnostic Product Solution and Service
Table 24. Date of Enter into Multiplex Molecular Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Multiplex Molecular Diagnostic Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Multiplex Molecular Diagnostic Revenue Market Share by Type (2018-2023)
Table 28. Global Multiplex Molecular Diagnostic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Multiplex Molecular Diagnostic Revenue Market Share by Type (2024-2029)
Table 30. Global Multiplex Molecular Diagnostic Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Multiplex Molecular Diagnostic Revenue Market Share by Application (2018-2023)
Table 32. Global Multiplex Molecular Diagnostic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Multiplex Molecular Diagnostic Revenue Market Share by Application (2024-2029)
Table 34. North America Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Multiplex Molecular Diagnostic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Multiplex Molecular Diagnostic Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Multiplex Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Multiplex Molecular Diagnostic Market Size by Country (2024-2029) & (US$ Million)
Table 49. BD Company Detail
Table 50. BD Business Overview
Table 51. BD Multiplex Molecular Diagnostic Product
Table 52. BD Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 53. BD Recent Development
Table 54. bioMйrieux Company Detail
Table 55. bioMйrieux Business Overview
Table 56. bioMйrieux Multiplex Molecular Diagnostic Product
Table 57. bioMйrieux Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 58. bioMйrieux Recent Development
Table 59. SpeeDx Company Detail
Table 60. SpeeDx Business Overview
Table 61. SpeeDx Multiplex Molecular Diagnostic Product
Table 62. SpeeDx Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 63. SpeeDx Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche Multiplex Molecular Diagnostic Product
Table 67. Roche Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Contextual Genomics Company Detail
Table 70. Contextual Genomics Business Overview
Table 71. Contextual Genomics Multiplex Molecular Diagnostic Product
Table 72. Contextual Genomics Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 73. Contextual Genomics Recent Development
Table 74. GenMark Diagnostics Company Detail
Table 75. GenMark Diagnostics Business Overview
Table 76. GenMark Diagnostics Multiplex Molecular Diagnostic Product
Table 77. GenMark Diagnostics Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 78. GenMark Diagnostics Recent Development
Table 79. Hologic Company Detail
Table 80. Hologic Business Overview
Table 81. Hologic Multiplex Molecular Diagnostic Product
Table 82. Hologic Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 83. Hologic Recent Development
Table 84. Luminex Corporation Company Detail
Table 85. Luminex Corporation Business Overview
Table 86. Luminex Corporation Multiplex Molecular Diagnostic Product
Table 87. Luminex Corporation Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 88. Luminex Corporation Recent Development
Table 89. Binx Health Company Detail
Table 90. Binx Health Business Overview
Table 91. Binx Health Multiplex Molecular Diagnostic Product
Table 92. Binx Health Revenue in Multiplex Molecular Diagnostic Business (2018-2023) & (US$ Million)
Table 93. Binx Health Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Multiplex Molecular Diagnostic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Multiplex Molecular Diagnostic Market Share by Type: 2022 VS 2029
Figure 3. Real-time PCR Features
Figure 4. Nested PCR with Melt Curve Analysis Features
Figure 5. PCR with Low density Microarray Features
Figure 6. PCR with Liquid Phase Bead Array Features
Figure 7. PCR with Electrochemical Detection Features
Figure 8. Global Multiplex Molecular Diagnostic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Multiplex Molecular Diagnostic Market Share by Application: 2022 VS 2029
Figure 10. Clinical Research Laboratory Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Academic and Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Multiplex Molecular Diagnostic Report Years Considered
Figure 15. Global Multiplex Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Multiplex Molecular Diagnostic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Multiplex Molecular Diagnostic Market Share by Region: 2022 VS 2029
Figure 18. Global Multiplex Molecular Diagnostic Market Share by Players in 2022
Figure 19. Global Top Multiplex Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Molecular Diagnostic as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Multiplex Molecular Diagnostic Revenue in 2022
Figure 21. North America Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 23. United States Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 27. Germany Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Multiplex Molecular Diagnostic Market Share by Region (2018-2029)
Figure 35. China Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 43. Mexico Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Multiplex Molecular Diagnostic Market Share by Country (2018-2029)
Figure 47. Turkey Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Multiplex Molecular Diagnostic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. BD Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 50. bioMйrieux Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 51. SpeeDx Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 53. Contextual Genomics Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 54. GenMark Diagnostics Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 55. Hologic Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 56. Luminex Corporation Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 57. Binx Health Revenue Growth Rate in Multiplex Molecular Diagnostic Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed